First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...

A review of recent studies suggests exercise may treat depression as effectively as therapy or antidepressants, offering an ...

A chronic condition affecting about a million Americans, Crohn’s disease causes inflammation in the digestive tract, leading to symptoms of diarrhea, cramping, abdominal pain and weight loss. Steroids ...

A recent research review shows that exercise may be nearly as effective as therapy in managing depression. However, experts ...

A randomized trial found an online behaviour change intervention did not increase physical activity in adults with asthma, ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

The estimated 280 million people worldwide who suffer from depression could have a treatment option that is not only cheaper ...

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...

Cardiff Oncology (CRDF) remains a single-asset biotech, with its thesis reliant on onvansertib targeting PLK1 in difficult-to ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...